{
  "ticker": "LCL",
  "pdf_display_url": "https://www.asx.com.au/asx/v2/statistics/displayAnnouncement.do?display=pdf&idsId=02961978",
  "id": "02961978",
  "pages": 6,
  "price_sensitive": false,
  "date": "20250625",
  "time": "1446",
  "pdf_url": "https://announcements.asx.com.au/asxpdf/20250625/pdf/06l34mfgwznnq2.pdf",
  "summary": "**Summary of Appendix 3Y - Change of Director\u2019s Interest Notices:**  \n\n- **Christopher van Wijk (Director):**  \n  - **Acquired:** 2,222,222 ordinary shares (indirectly via trust/super fund) on 25 June 2025.  \n  - **Consideration:** $20,000 (implied price: ~$0.009/sh).  \n  - **Holding post-change:**  \n    - Indirect: 2,222,222 ordinary shares (split across trusts).  \n    - Direct: 11,875,000 Performance Rights (expiring 30 Apr 2026 and 30 Apr 2027).  \n\n- **Christopher Knee (Director):**  \n  - **Acquired:** 2,222,222 ordinary shares (indirectly via trust) on 25 June 2025.  \n  - **Consideration:** $20,000 (implied price: ~$0.009/sh).  \n  - **Holding post-change:**  \n    - Indirect: 2,222,222 ordinary shares (trust) + 11,875,000 Performance Rights (expiring Oct 2026/2027).  \n\n**Key Takeaway:**  \n- Directors increased equity exposure at nominal cost (~$0.009/sh), signaling potential alignment with shareholders. No trading during closed period.  \n\n**Note:** No material capital markets or liquidity impact identified.",
  "usage": {
    "prompt_tokens": 2068,
    "completion_tokens": 296,
    "total_tokens": 2364,
    "prompt_tokens_details": null
  },
  "model": "deepseek/deepseek-chat-v3-0324:free",
  "processed_at": "2025-06-25T05:55:52.497234"
}